Incidental Detection of Second Primary Thyroid Malignancy in Patients of Metastatic Castration-Resistant Prostate Carcinoma: Documentation on 68 Ga-PSMA-11 and 64 CuCl 2 PET/CT

Clin Nucl Med. 2024 Aug 1;49(8):e396-e398. doi: 10.1097/RLU.0000000000005287. Epub 2024 May 14.

Abstract

Second primary tumors are being increasingly detected owing to and in proportion to the use of advanced imaging modalities including PET/CT. Patients suffering from prostate cancer have been reported to have increased second primary cancers of gastrointestinal tract, urinary bladder, and thyroid. We herein describe incidental detection of thyroid carcinoma, in 2 patients of mCRPC (metastatic castration-resistant prostate carcinoma) undergoing preradioligand therapy workup, on 68 Ga-prostate-specific membrane antigen PET/CT initially, subsequently also observed on multitracer PET/CT ( 64 CuCl 2 and 18 F-FDG). Thus, the potential of PET/CT for early in vivo second primary detection in mCRPC setting is illustrated in the aforementioned 2 patients.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Edetic Acid* / analogs & derivatives
  • Gallium Isotopes*
  • Gallium Radioisotopes*
  • Humans
  • Incidental Findings*
  • Male
  • Neoplasm Metastasis
  • Neoplasms, Second Primary / diagnostic imaging
  • Oligopeptides*
  • Positron Emission Tomography Computed Tomography*
  • Prostatic Neoplasms, Castration-Resistant* / diagnostic imaging
  • Prostatic Neoplasms, Castration-Resistant* / pathology
  • Thyroid Neoplasms* / diagnostic imaging
  • Thyroid Neoplasms* / pathology

Substances

  • gallium 68 PSMA-11
  • Gallium Isotopes
  • Gallium Radioisotopes
  • Edetic Acid
  • Oligopeptides
  • PSMA-11